← All companies

KTTA

Pasithea Therapeutics Corp.

KTTA Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.45

+0.00 +0.59%

Key statistics

from XBRL data in SEC filings

Market cap

$14.9M

Revenue (TTM)

$487K

Net income (TTM)

-$19.7M

EPS (TTM)

$-1.42

P/E ratio

—

Dividend yield

—

Free cash flow

-$15.2M

Cash

$50.4M

Total assets

$56.4M

Gross margin

-0.5%

52-week range

$0.28 – $2.06

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Director or officer change; Regulation FD disclosure May 4, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Delisting notice or listing-rule failure Feb 20, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jan 28, 2026 8-K Other events Dec 15, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 2, 2025 8-K Regulation FD disclosure; Other events Nov 25, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Regulation FD disclosure; Other events Nov 4, 2025 8-K Director or officer change Oct 27, 2025 8-K Regulation FD disclosure; Other events Sep 16, 2025 8-K Director or officer change; Shareholder vote results Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Item 5.08 Jul 11, 2025 8-K Delisting notice or listing-rule failure Jun 27, 2025 8-K Other events Jun 20, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement; Regulation FD disclosure May 7, 2025 8-K Changed accountants Apr 25, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Entered a material agreement Nov 26, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Sep 30, 2024 8-K Regulation FD disclosure Sep 26, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Shareholder vote results Jun 26, 2024 8-K Item 5.08 May 14, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 10-K Fiscal year ended 2023-12-31 Mar 29, 2024 8-K Other events Jan 18, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jan 2, 2024 8-K Modified rights of security holders; Amended charter or bylaws Dec 28, 2023 8-K Director or officer change; Shareholder vote results Dec 19, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Item 5.08 Oct 13, 2023 8-K Regulation FD disclosure; Other events Sep 14, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023 8-K Other events Jul 20, 2023 8-K Delisting notice or listing-rule failure Jul 20, 2023